FDA experts endorse Teva’s asthma drug, but reject use in key patient group – FierceBiotech


Fox News

FDA experts endorse Teva's asthma drug, but reject use in key patient group
FierceBiotech
An FDA advisory panel has handed Teva ($TEVA) a ringing endorsement for its IL-5 asthma drug reslizumab, offering a unanimous recommendation for marketing approval. That recommendation should quickly put it in direct rivalry with GlaxoSmithKline …
FDA advisers recommend approval of Teva asthma drug in adultsFox News
US FDA advisers recommend approval of Teva asthma drug for adultsReuters
FDA Advisory Committee Recommends Approval of Teva's Asthma Biologic ReslizumabBusiness Wire (press release)

all 110 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.